Clinical manifestation and the risk of exposure to SARS-CoV-2 (COVID-19)

Aleebrahim-Dehkordi, Elahe; Reyhanian, Ali; Hasanpour-Dehkordi, Ali

doi:10.4103/ijpvm.ijpvm_145_20

Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.

Int J Prev Med

2020

DOI: 10.4103/ijpvm.ijpvm_145_20

|View full text |Cite

Clinical manifestation and the risk of exposure to SARS-CoV-2 (COVID-19)

Elahe Aleebrahim-Dehkordi

Ali Reyhanian

Ali Hasanpour-Dehkordi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2023

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19

Struyf

Deeks

Dinnes

et al. 2022

Cochrane Database of Systematic Reviews

118

View full text Add to dashboard Cite

show abstract

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19

Struyf

Deeks

Dinnes

et al. 2022

Cochrane Database of Systematic Reviews

118

View full text Add to dashboard Cite

show abstract

Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19

Aleebrahim-Dehkordi

Ghoshouni

Koochaki

et al. 2023

Journal of Molecular Structure

View full text Add to dashboard Cite

Antiviral Compounds Based on Natural Astragalus polysaccharides (APS): Research and Foresight in the Strategies for Combating SARS-CoV-2 (COVID-19)

Dehkordi

Heidari-Soureshjani

Aryan

et al. 2022

MRMC

View full text Add to dashboard Cite

Today, finding natural polymers with desirable properties for use in various industries is one of the critical axes of research in the world. Polysaccharides are a group of natural polymers that have various applications in the pharmaceutical industry. The attachment of monosaccharides forms polysaccharides through glycosidic bonds that are widely found in various sources, including plants. Genus Astragalus belongs to the Fabaceae family. Plants belonging to this genus have different polysaccharides. Astragalus polysaccharides (APS) have attracted a great deal of attention among natural polymers discussed as suitable candidates for use in pharmaceutical formulations and preparation of new drugs to control COVID-19 infection because they are non-toxic, biodegradable, and biocompatible. Currently, APS has great drug potential for curing or treating various diseases. Due to the different biological activities of polysaccharides, including Astragalus, this study has investigated the chemical structure of APS, research report on antiviral, anti-inflammatory, and stimulation of cytokine secretion by these polysaccharides. Also, in this study, the pharmaceutical approaches of APS compounds, as a natural, new and inexpensive source, have been.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Clinical manifestation and the risk of exposure to SARS-CoV-2 (COVID-19)

Cited by 6 publications

References 11 publications

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19

Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19

Antiviral Compounds Based on Natural Astragalus polysaccharides (APS): Research and Foresight in the Strategies for Combating SARS-CoV-2 (COVID-19)

Contact Info

Product

Resources

About